Cargando…
Corrigendum to “Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD”
Autores principales: | Mao, Ke, Shu, Wanting, Liu, Libin, Gu, Qing, Qiu, Qinghua, Wu, XingWei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769678/ https://www.ncbi.nlm.nih.gov/pubmed/33414889 http://dx.doi.org/10.1155/2020/1769871 |
Ejemplares similares
-
Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD
por: Mao, Ke, et al.
Publicado: (2017) -
RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization
por: Zhang, Junxiu, et al.
Publicado: (2021) -
Corrigendum to “Effect of Selenium-Enriched Garlic Oil against Cytotoxicity Induced by OX-LDL in Endothelial Cells”
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2020) -
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study [Corrigendum]
Publicado: (2017) -
Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10]
por: Zafar, Sidra, et al.
Publicado: (2017)